Monica T.

Monica T. has extensive experience in pharmaceutical development and alliance management, currently serving in a leadership role at Daiichi Sankyo, Inc. since September 2017, where responsibilities include guiding the development and regulatory approval of controlled release opioids and managing CMC strategies for oncology products. Prior experience includes a Senior Manager position at Otsuka Pharmaceutical Companies, focusing on strategic leadership for global teams in M&A and in-licensing initiatives, as well as holding senior research scientist roles at Boehringer Ingelheim, where significant contributions to product approvals and CMC documentation were made. Monica began a career at Aprecia Pharmaceuticals as a scientist, leading innovative formulation development. Educational qualifications include a PhD in Pharmaceutical Sciences from Rutgers University and an MBA in Business Essentials from Rutgers Business School.